Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2000
12/12/2000US6159942 Administering a pentose to increase energy
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159696 Isolated human BMP-4 promoter region
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073444A1 Adipocyte complement related protein homolog zacrp5
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073331A2 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073292A1 Biaryl compounds
12/07/2000WO2000073271A1 Mutual salt of amlodipine and atorvastatin
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072920A1 Substituted biaryl ether compounds
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072832A2 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/07/2000WO2000072829A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072825A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000050456A3 Covalently bridged insulin dimers
12/07/2000CA2694866A1 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
12/07/2000CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375850A1 Method and compositions relating to insulin resistance disorders
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375822A1 Substituted biaryl ether compounds
12/07/2000CA2375674A1 Biaryl compounds
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374310A1 Nutritional supplements
12/07/2000CA2374288A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374117A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1057480A2 Transdermal estrogen agonist-antagonist therapy
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056856A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/06/2000EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects
12/06/2000EP1056776A1 Methods for treatment of diabetes using peptide analogues of insulin
12/06/2000EP1056775A1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action
12/06/2000EP1056774A1 N-terminally truncated glp-1 derivatives
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056701A1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000EP1056359A1 Product and method to reduce stress induced immune suppression
12/06/2000EP1056358A1 Use of d-tagatose as a prebiotic food component
12/06/2000EP1056357A1 Calorically dense nutritional composition
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000CN1275982A Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
12/06/2000CN1275918A Method and food product for increasing muscle protein and reducing fat in animals
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1275390A Ginkgo fat-reducing tea
12/06/2000CN1275375A Process for preparation of spraying granule of ovoflavin
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156802 Cholesterol-lowering composition
12/05/2000US6156786 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
12/05/2000US6156773 Pharmaceutical composition
12/05/2000US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives
12/05/2000US6156755 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156738 Controlling nighttime blood sugar level
12/05/2000US6156735 Arginine silicate inositol complex and use thereof
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000CA2188066C Thio-substituted phosphonate compounds
12/05/2000CA2136822C Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/05/2000CA1341151C Osmotic agents form peritoneal dialysis
12/05/2000CA1341149C Insulin receptor
12/04/2000WO2000075103A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) $g(a)
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071540A1 Hydrochloride of fused-heterocycle compound
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000WO2000071502A1 Hydrazide derivatives
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 1298